EKF Diagnostics (LON:EKF – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%.
EKF Diagnostics Stock Performance
Shares of EKF stock opened at GBX 22 ($0.28) on Tuesday. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The company has a market cap of £97.78 million, a PE ratio of 20.47 and a beta of 0.57. The company’s fifty day simple moving average is GBX 23.35 and its 200-day simple moving average is GBX 25.91. EKF Diagnostics has a 52 week low of GBX 18.40 ($0.24) and a 52 week high of GBX 33.80 ($0.44).
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- How to Invest in Blue Chip Stocks
- Top 3 Insider Stock Buys in March—Are They Still Good in April?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Pharma Frenzy: Volatility Ignites Biotech Sector
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Warren Buffett Thinks This Country Could Be the Next Big Bet
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
